In vitro precocious accumulation of calcium and matrix vesicles formation in young cartilage cells: specific effects of corticosteroids

Dexamethasone promotes calcium pyrophosphate dihydrate crystal formation by articular chondrocytes

OBJECTIVE

Calcium pyrophosphate dihydrate (CPPD) crystals are commonly found in osteoarthritic joints and correlate with a poor prognosis. Intraarticular corticosteroids, such as dexamethasone (Dxm), are commonly used therapies for osteoarthritis with or without CPPD deposition. Dxm has variable effects in mineralization models. We investigated the effects of Dxm on CPPD crystal formation in a well established tissue culture model.

METHODS

Porcine articular chondrocytes were incubated with ATP to generate CPPD crystals. Chondrocytes incubated with or without ATP were exposed to 1-100 nM Dxm in the presence of 45Ca. Mineralization was measured by 45Ca uptake in the cell layer. We also investigated the effect of Dxm on mineralization-regulating enzymes such as alkaline phosphatase, nucleoside triphosphate pyrophosphohydrolase (NTPPPH), and transglutaminase.

RESULTS

Dxm significantly increased ATP-induced mineralization by articular chondrocytes. While alkaline phosphatase and NTPPPH activities were unchanged by Dxm, transglutaminase activity increased in a dose-responsive manner. Levels of Factor XIIIA mRNA and protein were increased by Dxm, while type II Tgase protein was unchanged. Transglutaminase inhibitors suppressed Dxminduced increases in CPPD crystal formation.

CONCLUSION

These findings suggest a potential for Dxm to contribute to pathologic mineralization in cartilage and reinforce a central role for the transglutaminase enzymes in CPPD crystal formation.

Dexamethasone promotes von kossa-positive nodule formation and increased alkaline phosphatase activity in costochondral chondrocyte cultures

This study examined the effect of dexamethasone on von Kossa-positive nodule formation and alkaline phosphate specific activity of costochondral chondrocytes at two distinct stages of maturation. The nodules formed by the more mature growth zone chondrocyte cultures contained von Kossa-positive deposits in the extracellular matrix that had a punctate morphology. The nodules formed by the less mature resting zone cells also contained von Kossa-positive deposits, but differentiation was delayed by three-to-five days compared to the growth zone cell cultures. Dexamethasone stimulated the number of nodules formed and shortened the length of time required for von Kossa-positive nodule formation in both types of cultures. During the first 48 h of exposure to dexamethasone, alkaline phosphatase specific activity in the cell layer of both resting zone and growth zone cultures was increased in a dose-dependent manner. At 12 days post-confluence and thereafter, enzyme activity was inhibited in the dexamethasone-treated cultures. Changes in matrix vesicle alkaline phosphatase specific activity reflected those changes seen in the cell layer after dexamethasone treatment, but with higher magnitude, suggesting that one effect of dexamethasone might be to regulate matrix vesicle function. With the exception of one culture, the chondrocytes did not synthesize type X collagen under any of the experimental conditions used. Fourier transform infrared spectroscopy (FTIR) failed to detect the presence of calcium phosphates in any of the cultures exposed to dexamethasone except one. These results demonstrate that dexamethasone promotes early differentiation events, including nodule formation and increased alkaline phosphatase activity, in costochondral chondrocyte cultures. The failure to detect type X collagen synthesis and mineralization in both dexamamethasone-treated and control cultures suggests that these cultures lack the factors necessary for terminal differentiation and mineralization.

Interactions between growth hormone and dexamethasone in skeletal growth and bone structure of the young mouse

The present study investigated the interactions of growth hormone (GH) and glucocorticoid on skeletal growth and bone structure in young mice. The purpose of this study was to examine the possible prevention by GH of the damage inflicted by dexamethasone (Dex) at sites of skeletal growth and ossification. Dex (1 mg/kg) with or without rat GH (rGH) or bovine GH (bGH), 1 mg/kg, was given for 4 weeks, from age 3-7 weeks, to female ICR mice. Tibiae, humerus, and vertebrae were analyzed morphometrically and biochemically. Growth, as determined by the mouse weight, tibial length, and humerus protein content was found to be compromised by dexamethasone. This was prevented by rGH or bGH. The epiphyseal growth plate width, trabecular bone volume, cortical bone width, mineral bone content, and alkaline and acid phosphatase activity were decreased by dexamethasone. These were prevented by rGH or by bGH. The findings of the present study suggest that in the mouse, GH can decrease or even avoid some of the pathological features in growing bones inflicted by high-dose glucocorticoid treatment.

Growth and differentiation of murine cartilage cells in vitro following a short-term exposure to triamcinolone acetonide

Measurements of 3H-thymidine incorporation, quantitative autoradiography and morphometry were used to evaluate cell behavior during the recovery of mandibular condylar cartilage cultures following short-term exposure to a corticosteroid hormone in vitro. Apical segments of mandibular condyles of newborn mice were initially incubated in the presence of the hormone triamcinolone acetonide (10(-6) M) for 24 h and were thereafter cultured for additional 6 days in hormone-free medium. The present results indicated that the treatment led to a decrease in the rate of incorporation of 3H-thymidine, a feature that lasted for 48 h following the removal of the hormone. Quantitative 3H-thymidine autoradiography of explants that were labeled in the presence of the hormone further substantiated the initial suppressive effect of the hormone on cellular proliferation, a feature that was followed by a recovery. Differences were noted in the pattern of distribution of labeled cells: in control explants, labeled cells progressively moved from the chondroprogenitor compartment into the differentiated portion of the cartilage; in hormone-treated explants, 3H-thymidine labeled cells were confined to the progenitor layer up to 5 days after the treatment and only then appeared in the chondrocytic compartment. The hormone's adverse effect upon differentiation was manifested by both morphology, and by causing a significant increase in the size of the progenitor layer (up to 50.5% on 4th post-treatment day) along with a 70.5% reduction in the size of chondroblastic layer. We conclude that a short-term exposure to a glucocorticoid hormone in vitro interferes with proliferation of chondroprogenitor cells and their subsequent differentiative pathway.(ABSTRACT TRUNCATED AT 250 WORDS)

Effects of leukemogenic retroviruses on condylar cartilage in vitro: an ultrastructural study

Mandibular condyles of late embryonic NMRI mice were used in an in vitro organ culture system to study the effect of bone tumor-derived murine leukemia viruses OS-5 MuLV and OA MuLV known to induce osteopetrosis and osteomas. Skeletal precursor cells present in the condylar tissue normally undergo rapid differentiation in vitro which results in new bone formation. The infection of condyles with either OS-5 MuLV or OA MuLV markedly interfered with the normal developmental pattern of the organ leading to the formation of an atypical, heavily mineralized tissue. Many spindlelike cells and pleomorphic cells were encountered, whereas fibroblastlike cells were found to penetrate an underlying collagen substratum. These observations indicate that bone tumor-inducing leukemogenic retroviruses directly affect cartilage and/or bone precursor cells resulting in pathologic developments in the skeleton.

Supraphysiological concentrations of dexamethasone induce elevation of calcium uptake and depression of [3H]-thymidine incorporation into DNA in cartilage in vitro

When condylar cartilages of neonatal mice are treated in vitro with dexamethasone they respond with a significant depression of DNA synthesis. Concomitant with the retardative effect upon the incorporation of [3H]-thymidine, dexamethasone enhances the uptake of 45Ca by the condylar tissue. The hormone's effect upon calcium uptake is relatively rapid and takes place within 2 hours whereas the effect upon the incorporation of [3H]-thymidine takes place after a lag period of 24 hours. The present findings tend to indicate the casual relationship between the above effects of dexamethasone in fast growing cartilage. Further, there is evidence that both of the above responses are specific and are protein and mRNA synthesis dependent. Control studies using both a calcium ionophore (A23187) and a calcium blocker (D-600) provided data that further substantiate the proposed association among dexamethasone, calcium metabolism, and DNA synthesis in neonatal growth cartilage.